Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coinbase Global | Xetra | Technology | Financial Technology (Fintech) & Infrastructure | 118.3% | €84.34B | 65.8x | 13.14 | €327.35 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ceres Power | Frankfurt | Energy | Renewable Energy | 93.9% | €220.47M | -6.8x | -0.15 | €1.08 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ProQR Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | 92.2% | €209.08M | -6.2x | 4.02 | €1.96 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Frankfurt | Healthcare | Pharmaceuticals | 78.2% | €45.72M | -4.8x | 0.08 | €0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Xetra | Healthcare | Biotechnology & Medical Research | 72.8% | €1.05B | 5.8x | 0.04 | €4.65 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curevac | Frankfurt | Healthcare | Biotechnology & Medical Research | 67.2% | €1.05B | 5.8x | 0.04 | €4.62 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philomaxcap | Frankfurt | Technology | Financial Technology (Fintech) & Infrastructure | 62.7% | €197.50M | -6.2x | 0.64 | €1.79 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueprint Medicines | Frankfurt | Healthcare | Biotechnology & Medical Research | 55.7% | €7.16B | -52.7x | -1.12 | €108.75 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax | Frankfurt | Healthcare | Biotechnology & Medical Research | 39% | €451.29M | -2.4x | -0.22 | €6.88 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cosmo Pharmaceuticals NV | Frankfurt | Healthcare | Pharmaceuticals | 38.9% | €1.07B | 8.2x | 0.01 | €66.50 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dominari | Frankfurt | Financials | Investment Banking & Investment Services | 34.9% | €62.51M | -0.9x | 0.07 | €3.90 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invesco Mortgage Capital | Frankfurt | 29.3% | €432.13M | 16.1x | 0.11 | €6.55 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Kinnevik B | Frankfurt | Financials | Investment Holding Companies | 28.6% | €2.37B | -10.1x | -0.15 | €8.24 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Axsome Therapeutics | Frankfurt | Healthcare | Pharmaceuticals | 9.8% | €4.60B | -19x | -2 | €93.30 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonesupport | Frankfurt | Healthcare | Pharmaceuticals | 3.8% | €1.74B | 158.2x | -2.95 | €26.48 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
11 Bit Studios | Frankfurt | Technology | Software & IT Services | 2.9% | €106.52M | 215.4x | 1.35 | €44.98 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
2Invest | Xetra | Financials | Investment Holding Companies | 0% | €66.73M | 3x | 0 | €12.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
2Invest | Frankfurt | Financials | Investment Holding Companies | 0% | €66.73M | 3x | 0 | €12 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beta Systems Software | Frankfurt | Technology | Software & IT Services | -12% | €78.13M | 1.2x | 0 | €16.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MPH Health Care AG | Frankfurt | Healthcare | Pharmaceuticals | -16.9% | €78.99M | 2.5x | 0.29 | €18.45 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MPH Health Care AG | Xetra | Healthcare | Pharmaceuticals | -17.1% | €78.99M | 2.5x | 0.29 | €19.15 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |